Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Alvogen buys majority stake in Korea's Kunwha Pharmaceutical

Executive Summary

Alvogen Inc. acquired 50.5% of publicly traded Kunwha Pharmaceutical Co. Ltd., providing Alvogen with a South Korean presence and a platform upon which to expand throughout Asia. Media reports pegged the deal value at KRW100mm ($91mm).
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Acquisition
    • Partial Acquisition

Related Companies